Mammoscintigraphy with Technetium-99m-Sestamibi in Suspected Breast Cancer

Journal of Nuclear Medicine

Volumn 37, Issue 6, 1996, Pages 926-930

  Villanueva Meyer, J ^a,b   Leonard Jr , M H ^a   Briscoe, E ^a   Cesani, F ^a   Ali, S A ^a   Rhoden, S ^a   Hove, M ^a   Cowan, D ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Breast cancer; Technetium 99m sestamibi

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BIOPSY; BREAST; BREAST TUMOR; FEMALE; HUMAN; MAMMOGRAPHY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RADIOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0030161486     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Harris JR, Lippman ME, Veronesi U, Willett W. Breast cancer. N Engl J Med 1992;327:319-328.
2. Shapiro S, Venet W, Strax P. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349-355.
3. Van Dam PA, Van Goethmen MLA, Kersschot E, et al. Palpable solid breast masses: retrospective single- and multimodality evaluation of 201 lesions. Radiology 1988;166:435-439.
4. Feig SA, Shaber GA, Patchefskly A. Analysis of clinically occult and mammographically occult breast tumors. AJR 1977;128:403-408.
5. Kopans DB. Positive predictive value of mammography. AJR 1992;158:521-526.
6. Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at the screening mammography. Radiology 1992;184:613-617.
7. 201Tl. J Nucl Med 1993;34:1949-1952.
8. 201Tl in unsuspected breast tumor. Clin Nucl Med 1992;17:936-937.
9. 99mTc-sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995;196:421-426.
10. 99mTc-methoxy isobutyl isonitrile (MIBI) in the evaluation of patients with primary carcinoma of the breast. Clin Nucl Med 1992;9:761.
11. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994;178:491-497.
12. 99mTc-sestamibi. Eur J Nucl Med 1994;21:357-362.
13. Khalkhali I, Cutrone J, Mena I, et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995;36:1784-1789.
14. 201Tl [Abstract]. J Nucl Med 1993;34 (suppl):139P.
15. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-1765.
16. Kao CH, Wang SJ, Yeh SH. Technetium-99m-MIBI uptake in breast carcinoma and axillary lymph node metastases. Clin Nucl Med 1994;19:898-900.
17. Villanueva-Meyer J, Leonard Jr MH, Ali SA, Cesani K, Kumar D. Technetium-99m-sestamibi in the evaluation of mammographic abnormalities [Abstract]. J Nucl Med 1994;35 (suppl):219P.
18. 99mTc-sestamibi [Abstract]. Radiology 1994;193:423.
19. Waxman AD, Ramanna L, Memsic LD, et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993;34:18-23.
20. Lee VW, Sax EJ, McAneny DB, et al. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J Nucl Med 1993;34:2095-2100.
21. Cimitan M, Volpe R, Candiani E, et al. The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography. Eur J Nucl Med 1995:22:1110-1117.
22. Johnson LV, Walsb ML, Bockus BJ, Chen LB. Monitoring of relative mitochondrial membrane potential in living cells by fluorescence relative mitochondrial membrane potential in living cells by fluorescence microscopy. J Cell Biol 1981;88:526-535.
23. Summerhayes IC, Lampidis TJ, Bernal SD, et al. Unusual retention of rhodamine-123 by mitochondria in muscle and carcinoma cells. Proc Nat Acad Sci USA 1982;79:5292-5296.
24. Nadakavukaren KK, Nadakavukaren JJ, Chen LB. Increased rhodamine-123 uptake by carcinoma cells. Cancer Res 1985;45:6093-6097.
25. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davidson A, Jones AG. Uptake of the cation hexakis(2-methoxyisobutyl-isonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990;50:2198-2202.
26. Picwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977-984.
27. 99mTc-sestamibi scanning in the breast. Mod Pathol 1995;8:1:19a.
28. Scopinaro F, Schillaci O, Scarpini M, et al. Technetium-99m-sestamibi: an indicator of breast cancer invasiveness. Eur J Nucl Med 1994;21:984-987.
29. Piccolo S, Lastoria S, Mainolfi C, Muto P, Bazzicalupo L, Salvatore M. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer. J Nucl Med 1995;36:718-725.
30. Van Eijck CHJ, Krenning EP, Bootsma A, et al. Somatostatin receptor scintigraphy of primary breast cancer and its predictive value in the follow-up in comparison with CEA and CA 15-3 [Abstract]. J Nucl Med 1994;35 (suppl):21P.
31. Nieweg O, Kim E, Wong WH, et al. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 1993;71:3920-3925.
32. 18F]2-deoxy-2-fluoro-d-glucose PET. Radiology 1993;187:743-750.
33. Crane PD, Onthank DC, Bourque CR, et al. Autoradiography and radioscintigraphy of technetium-99m-sestamibi in c-neu transgenic mice. J Nucl Med 1995;36:1862-1868.
34. Dehdashti F, Mortimer JE, Siegel BA, et al. Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med 1995;36:1766-1774.
35. 99mTc and radioiodine. Cancer Res 1994;54:4162-4168.
36. Weinreb JC, Newstead G. MR imaging of the breast. Radiology 1995;196:593-610.
37. Palmedo H, Schonburg A, Grunwald F, Mallmann P, Krebs D, Biersack HJ. Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 1996;37:626-630.